Nihon Kohden Corporation (JP:6849)
:6849
6849 Stock Chart & Stats
¥1683.00
-¥5.00(-0.24%)
At close: 4:00 PM EST
¥1683.00
-¥5.00(-0.24%)
Day’s Range― - ―
52-Week Range¥1,415.50 - ¥1,885.50
Previous CloseN/A
Volume364.00K
Average Volume (3M)516.53K
Market Cap
¥255.76B
Enterprise Value¥231.15B
Total Cash (Recent Filing)¥44.00B
Total Debt (Recent Filing)¥25.55B
Price to Earnings (P/E)36.4
Beta0.84
Next Earnings
May 14, 2026EPS Estimate
35.82Next Dividend Ex-DateN/A
Dividend Yield1.92%
Share Statistics
EPS (TTM)11.57
Shares Outstanding170,961,960
10 Day Avg. Volume572,580
30 Day Avg. Volume516,533
Financial Highlights & Ratios
PEG Ratio-1.46
Price to Book (P/B)1.85
Price to Sales (P/S)1.48
P/FCF Ratio40.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)95.1
Revenue Forecast (FY)¥231.34B
Bulls Say, Bears Say
Bulls Say
Revenue Growth MomentumSustained TTM revenue growth of ~8.7% indicates ongoing demand for core monitoring and diagnostic products. Durable top-line expansion supports recurring consumable and service sales from the installed base, enabling multi-quarter revenue visibility and reinvestment in product development.
Conservative Balance SheetVery low leverage provides financial flexibility to fund R&D, service expansion, and overseas distribution without stressing liquidity. A conservative capital structure reduces bankruptcy risk and preserves capacity for strategic investments or cyclical pressure over the next several quarters.
High Gross Margin BaseA ~52% gross margin signals product differentiation and pricing power in medical devices and accessories. Strong gross economics support durable profitability on installed-base driven consumable sales and justify continued investment in clinical IT and telemetry offerings that sustain long-term margins.
Bears Say
Net Margin CompressionTrailing net margin near 5.4% and year-on-year compression indicate rising cost pressure or unfavorable product mix. Persisting margin erosion reduces retained earnings available for capex and dividends and weakens profitability resilience against slower demand or higher input costs.
Volatile Free Cash FlowFCF conversion of ~61% and sharply negative FCF growth point to uneven cash generation driven by working-capital or investment swings. Erratic cash flow limits reliable funding for buybacks, acquisitions, or higher dividends and raises execution risk over coming quarters.
Step-up In DebtAlthough leverage remains low, a recent increase from near-zero levels reduces the margin of safety versus prior years. Even modest additional debt raises interest and refinancing exposure and slightly constrains capacity for opportunistic M&A or large capital outlays.
Nihon Kohden Corporation News
6849 FAQ
What was Nihon Kohden Corporation’s price range in the past 12 months?
Nihon Kohden Corporation lowest stock price was ¥1415.50 and its highest was ¥1885.50 in the past 12 months.
What is Nihon Kohden Corporation’s market cap?
Nihon Kohden Corporation’s market cap is ¥255.76B.
When is Nihon Kohden Corporation’s upcoming earnings report date?
Nihon Kohden Corporation’s upcoming earnings report date is May 14, 2026 which is in 37 days.
How were Nihon Kohden Corporation’s earnings last quarter?
Nihon Kohden Corporation released its earnings results on Feb 05, 2026. The company reported ¥11.57 earnings per share for the quarter, missing the consensus estimate of ¥12.988 by -¥1.418.
Is Nihon Kohden Corporation overvalued?
According to Wall Street analysts Nihon Kohden Corporation’s price is currently Overvalued.
Does Nihon Kohden Corporation pay dividends?
Nihon Kohden Corporation pays a Semiannually dividend of ¥16 which represents an annual dividend yield of 1.92%. See more information on Nihon Kohden Corporation dividends here
What is Nihon Kohden Corporation’s EPS estimate?
Nihon Kohden Corporation’s EPS estimate is 35.82.
How many shares outstanding does Nihon Kohden Corporation have?
Nihon Kohden Corporation has 170,961,960 shares outstanding.
What happened to Nihon Kohden Corporation’s price movement after its last earnings report?
Nihon Kohden Corporation reported an EPS of ¥11.57 in its last earnings report, missing expectations of ¥12.988. Following the earnings report the stock price went up 1.08%.
Which hedge fund is a major shareholder of Nihon Kohden Corporation?
Currently, no hedge funds are holding shares in JP:6849
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nihon Kohden Corporation
Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Rion Co., Ltd.
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---